Carbapenem-resistant Enterobacteriaceae (CRE): Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<!-- Do not edit this line-->{{Curated}} | |||
==Section== | |||
[[Image:PHIL_1181_lores.jpg|thumb|300px|right|Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the [http://www.cdc.gov/ CDC].]] | |||
<br>By [My Name]<br> | |||
<br>At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.<br><br>The insertion code consists of: | |||
<br><b>Double brackets:</b> [[ | |||
<br><b>Filename:</b> PHIL_1181_lores.jpg | |||
<br><b>Thumbnail status:</b> |thumb| | |||
<br><b>Pixel size:</b> |300px| | |||
<br><b>Placement on page:</b> |right| | |||
<br><b>Legend/credit:</b> Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the [http://www.cdc.gov/ CDC]. | |||
<br><b>Closed double brackets:</b> ]] | |||
<br><br>Other examples: | |||
<br><b>Bold</b> | |||
<br><i>Italic</i> | |||
<br><b>Subscript:</b> H<sub>2</sub>O | |||
<br><b>Superscript:</b> Fe<sup>3+</sup> | |||
Carbapenem-resistant <I>Enterobacteriaceae</I> (CRE) are a family of Gram-negative bacteria that are resistant to carbapenem, a class of anti-biotics used to treat infections. Carbapenems offer a broad-spectrum defense against a wide variety of both Gram-negative and Gram-positive bacteria, meaning that increasing resistance by CRE, to which there is no reliable treatment, is a major concern for the health industry. [2,3] Previously rare in the United States before 1992, CRE are becoming increasingly more common.[1] Although <I>Enterobacteriaceae</I> are normal human intestinal flora, resistance may be caused by the occurrence of hydrolyzing enzymes, such as serine β-lactamase KPC and the metallo–β-lactamase VIM.[3] Resistance to carbapenems is common in a number of <I>Enterobacteriaceae</I>, such as Kelbsiella pneumoniae and E. coli [3]. CRE typically cause infections in patients of hospitals and nursing homes [3]. The increasing prevalence and lack of reliable treatment have led many to predict CRE as the next "superbug." [3] | |||
<br>Introduce the topic of your paper. What is your research question? What experiments have addressed your question? Applications for medicine and/or environment?<br> | |||
Sample citations: <ref>[http://www.plosbiology.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pbio.1000005&representation=PDF Hodgkin, J. and Partridge, F.A. "<i>Caenorhabditis elegans</i> meets microsporidia: the nematode killers from Paris." 2008. PLoS Biology 6:2634-2637.]</ref> | |||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ Bartlett et al.: Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.]</ref> | |||
<br><br>A citation code consists of a hyperlinked reference within "ref" begin and end codes. | |||
==Section 1== | |||
Include some current research, with at least one figure showing data.<br> | |||
<br> | |||
Every point of information REQUIRES CITATION using the citation tool shown above. | |||
==Section 2== | |||
Include some current research, with at least one figure showing data.<br> | |||
<br> | |||
==Section 3== | |||
Include some current research, with at least one figure showing data.<br> | |||
<br> | |||
==Section 4== | |||
=== | ==Conclusion== | ||
==References== | ==References== | ||
(1) Neil Gupta, Brandi M. Limbago, Jean B. Patel, Alexander J. Kallen; Carbapenem-Resistant <I>Enterobacteriaceae</I>: Epidemiology and Prevention. Clin Infect Dis 2011; 53 (1): 60-67. doi: 10.1093/cid/cir202 | (1) Neil Gupta, Brandi M. Limbago, Jean B. Patel, Alexander J. Kallen; Carbapenem-Resistant <I>Enterobacteriaceae</I>: Epidemiology and Prevention. Clin Infect Dis 2011; 53 (1): 60-67. doi: 10.1093/cid/cir202 | ||
Line 11: | Line 48: | ||
(3)http://jamanetwork.com/journals/jama/fullarticle/183101 | (3)http://jamanetwork.com/journals/jama/fullarticle/183101 | ||
<br><br>Authored by Carter Powell for BIOL 238 Microbiology, taught by [mailto:slonczewski@kenyon.edu Joan Slonczewski], 2017, [http://www.kenyon.edu/index.xml Kenyon College]. | |||
Edited by Carter Powell for BIOL 238 Microbiology, 2017, Kenyon College. | Edited by Carter Powell for BIOL 238 Microbiology, 2017, Kenyon College. |
Revision as of 15:21, 5 April 2017
Section
By [My Name]
At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.
The insertion code consists of:
Double brackets: [[
Filename: PHIL_1181_lores.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit: Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the CDC.
Closed double brackets: ]]
Other examples:
Bold
Italic
Subscript: H2O
Superscript: Fe3+
Carbapenem-resistant Enterobacteriaceae (CRE) are a family of Gram-negative bacteria that are resistant to carbapenem, a class of anti-biotics used to treat infections. Carbapenems offer a broad-spectrum defense against a wide variety of both Gram-negative and Gram-positive bacteria, meaning that increasing resistance by CRE, to which there is no reliable treatment, is a major concern for the health industry. [2,3] Previously rare in the United States before 1992, CRE are becoming increasingly more common.[1] Although Enterobacteriaceae are normal human intestinal flora, resistance may be caused by the occurrence of hydrolyzing enzymes, such as serine β-lactamase KPC and the metallo–β-lactamase VIM.[3] Resistance to carbapenems is common in a number of Enterobacteriaceae, such as Kelbsiella pneumoniae and E. coli [3]. CRE typically cause infections in patients of hospitals and nursing homes [3]. The increasing prevalence and lack of reliable treatment have led many to predict CRE as the next "superbug." [3]
Introduce the topic of your paper. What is your research question? What experiments have addressed your question? Applications for medicine and/or environment?
Sample citations: [1]
[2]
A citation code consists of a hyperlinked reference within "ref" begin and end codes.
Section 1
Include some current research, with at least one figure showing data.
Every point of information REQUIRES CITATION using the citation tool shown above.
Section 2
Include some current research, with at least one figure showing data.
Section 3
Include some current research, with at least one figure showing data.
Section 4
Conclusion
References
(1) Neil Gupta, Brandi M. Limbago, Jean B. Patel, Alexander J. Kallen; Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention. Clin Infect Dis 2011; 53 (1): 60-67. doi: 10.1093/cid/cir202
(2)http://prod.hopkins-abxguide.org/antibiotics/antibacterial/carbapenem/ertapenem.html
(3)http://jamanetwork.com/journals/jama/fullarticle/183101
Authored by Carter Powell for BIOL 238 Microbiology, taught by Joan Slonczewski, 2017, Kenyon College.
Edited by Carter Powell for BIOL 238 Microbiology, 2017, Kenyon College.